FGFR3 and central nervous system cancer: In FGFR3-TACC3 fusion-positive gliomas, the fused FGFR3 loses its 3′ UTR region; therefore, it is no longer negatively regulated by miR-99a, which increases the FGFR3 tyrosine kinase signal, thereby promoting tumor progression [46].